Intrexon | XON - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Agenus USD 39.17M 49.8M 2026-03
Alaunos Therapeutics USD -1.01M 153K 2026-03
Amgen USD 2.38B 556M 2026-06
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -194.28M 61.55M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Incyte USD 585.6M 282.27M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Ligand Pharmaceuticals USD 48.51M 61.85M 2026-06
MacroGenics USD -36.77M 22.62M 2026-03
MannKind USD -16.62M 671K 2026-03
Merck USD -1.34B 2.9B 2026-06
Novartis USD 3.26B 108M 2026-06
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Roche Holding CHF 6.87B 1.4B 2026-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Thermo Fisher Scientific USD 1.74B 85M 2026-06
Veracyte USD 25.49M 3.22M 2026-06
Xencor USD -21.73M 107.19M 2026-06